RANDOMIZED STUDY OF PREOPERATIVE VERSUS POSTOPERATIVE RADIATION-THERAPY IN ADVANCED HEAD AND NECK-CARCINOMA - LONG-TERM FOLLOW-UP OF RTOG STUDY 73-03

被引:173
作者
TUPCHONG, L
SCOTT, CB
BLITZER, PH
MARCIAL, VA
LOWRY, LD
JACOBS, JR
STETZ, J
DAVIS, LW
SNOW, JB
CHANDLER, R
KRAMER, S
PAJAK, TF
机构
[1] RADIAT THERAPY ONCOL GRP,STAT UNIT,PHILADELPHIA,PA
[2] REG RADIAT CTR,FT MYERS,FL
[3] THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT OTOLARYNGOL,PHILADELPHIA,PA 19107
[4] UNIV PUERTO RICO,CTR CANC,DIV RADIOTHERAPY,RIO PIEDRAS,PR 00931
[5] WAYNE STATE UNIV,SCH MED,DEPT OTOLARYNGOL,DETROIT,MI 48201
[6] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT RADIAT THERAPY,BRONX,NY 10461
[7] HOSP UNIV PENN,DEPT OTOLARYNGOL,PHILADELPHIA,PA 19104
[8] UNIV MIAMI,SCH MED,MIAMI,FL 33152
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1991年 / 20卷 / 01期
关键词
HEAD AND NECK CARCINOMA; SQUAMOUS CELL; COMBINED MODALITY; PREOPERATIVE IRRADIATION; POSTOPERATIVE IRRADIATION; SUPRAGLOTTIC LARYNX; RANDOMIZED STUDY; ADJUVANT THERAPY; 2ND PRIMARY; DISTANT METASTASES;
D O I
10.1016/0360-3016(91)90133-O
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This is a report of a 10-year median follow-up of a randomized, prospective study investigating the optimal sequencing of radiation therapy (RT) in relation to surgery for operable advanced head and neck cancer. In May 1973, the Radiation Therapy Oncology Group (RTOG) began a Phase III study of preoperative radiation therapy (50.0 Gy) versus postoperative radiation therapy (60.0 Gy) for supraglottic larynx and hypopharynx primaries. Of 277 evaluable patients, duration of follow-up is 9-15 years, with 7.6% patients lost to follow-up before 7 years. Loco-regional control was sigificantly better for 141 postoperative radiation therapy patients than for 136 preoperative radiation therapy patients (p = 0.04), but absolute survival was not affected (p = 0.15). When the analysis was restricted to supraglottic larynx primaries (60 postoperative radiation therapy patients versus 58 preoperative radiation therapy patients), the difference for loco-regional control was highly significant (p = .007), but not for survival (p = 0.18). In considering only supraglottic larynx, 78% of loco-regional failures occurred in the first 2 years. Thirty-one percent (18/58) of preoperative patients failed locally within 2 years versus 18% (11/60) of postoperative patients. After 2 years, distant metastases and second primaries became the predominant failure pattern, especially in postoperative radiation therapy patients. This shift in the late failure pattern along with the increased number of unrelated deaths negated any advantage in absolute survival for postoperative radiation therapy patients. The rates of severe surgical and radiation therapy complications were similar between the two arms. Because of an increased incidence of late distant metastases and secondary primaries, additional therapeutic intervention is required beyond surgery and postoperative irradiation to impact significantly upon survival.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 39 条
[1]  
ARRIAGADA R, 1983, CANCER, V51, P1819, DOI 10.1002/1097-0142(19830515)51:10<1819::AID-CNCR2820511011>3.0.CO
[2]  
2-G
[3]   PATTERNS OF FAILURE AND RESULTS OF PREOPERATIVE IRRADIATION VS RADIATION-THERAPY ALONE IN CARCINOMA OF THE PYRIFORM SINUS [J].
BYHARDT, RW ;
COX, JD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1980, 6 (09) :1135-1141
[4]   COMBINATION OF RADIOTHERAPY AND SURGERY IN TREATMENT OF HEAD AND NECK CANCERS [J].
CACHIN, Y ;
ESCHWEGE, F .
CANCER TREATMENT REVIEWS, 1975, 2 (03) :177-191
[5]   COMPLICATIONS OF HIGH DOSE PREOPERATIVE IRRADIATION FOR ADVANCED LARYNGEAL-HYPOPHARYNGEAL CANCER [J].
CHUNG, CT ;
SAGERMAN, RH ;
KING, GA ;
YU, WS ;
JOHNSON, JT ;
CUMMINGS, CW .
RADIOLOGY, 1978, 128 (02) :467-470
[6]  
CREWS QE, 1971, AM J ROENTGENOL, V11, P73
[7]  
FLETCHER GH, 1977, CANCER, V39, P862, DOI 10.1002/1097-0142(197702)39:2+<862::AID-CNCR2820390723>3.0.CO
[8]  
2-7
[9]  
FLETCHER GH, 1972, CANCER-AM CANCER SOC, V29, P1450, DOI 10.1002/1097-0142(197206)29:6<1450::AID-CNCR2820290605>3.0.CO
[10]  
2-Q